methotrexate has been researched along with Uveitis, Posterior in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, P; Thomas, AS | 1 |
| Akhlaghi, M; Ashofteh, F; Chams-Davatchi, C; Davatchi, F; Faezi, T; Nadji, A; Sadeghi Abdollahi, B; Shahram, F; Shams, H | 1 |
| Akhlaghi, M; Chams-Davatchi, C; Davatchi, F; Faezi, T; Naderi, N; Nadji, A; Rezaipoor, M; Sadeghi-Abdollahi, B; Shahram, F; Shams, H | 1 |
| Oguzhan, O; Tayfun, B; Umur, KA | 1 |
| Hazirolan, D; Pleyer, U | 1 |
| Akbarian, M; Chams, C; Chams, H; Davatchi, F; Gharibdoost, F; Jamshidi, AR; Nadji, A; Shahram, F | 1 |
| Dick, AD; Hogan, A; Lee, R; Ramanan, AV; Sharma, S; Teoh, SC | 1 |
3 review(s) available for methotrexate and Uveitis, Posterior
| Article | Year |
|---|---|
Local treatment of infectious and noninfectious intermediate, posterior, and panuveitis: current concepts and emerging therapeutics.
Topics: Anti-Infective Agents; Drug Implants; Eye Infections, Bacterial; Fluocinolone Acetonide; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Panuveitis; Rituximab; Sirolimus; Uveitis, Intermediate; Uveitis, Posterior | 2020 |
Different ophthalmologic manifestations of sarcoidosis.
Topics: Adult; Biopsy; Female; Horner Syndrome; Humans; Immunosuppressive Agents; Methotrexate; Optic Nerve Diseases; Pars Planitis; Sarcoidosis; Uveitis, Posterior | 2012 |
Think global--act local: intravitreal drug delivery systems in chronic noninfectious uveitis.
Topics: Angiogenesis Inhibitors; Animals; Chronic Disease; Drug Delivery Systems; Drug Implants; Glucocorticoids; Humans; Intravitreal Injections; Methotrexate; Tumor Necrosis Factor-alpha; Uveitis, Posterior; Vascular Endothelial Growth Factor A; Vitreous Body | 2013 |
2 trial(s) available for methotrexate and Uveitis, Posterior
| Article | Year |
|---|---|
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Behcet Syndrome; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Iran; Male; Methotrexate; Middle Aged; Papilledema; Pilot Projects; Prednisolone; Retinal Vasculitis; Rituximab; Severity of Illness Index; Single-Blind Method; Time Factors; Treatment Outcome; Uveitis, Anterior; Uveitis, Posterior; Visual Acuity; Young Adult | 2010 |
High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
Topics: Behcet Syndrome; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Methotrexate; Retinal Vasculitis; Time Factors; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 2003 |
2 other study(ies) available for methotrexate and Uveitis, Posterior
| Article | Year |
|---|---|
Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Capsule Opacification; Drug Therapy, Combination; Glucocorticoids; Humans; Longitudinal Studies; Methotrexate; Prednisolone; Recovery of Function; Registries; Retinal Vasculitis; Severity of Illness Index; Time Factors; Treatment Outcome; Uveitis, Anterior; Uveitis, Posterior; Visual Acuity | 2013 |
Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome.
Topics: Anti-Inflammatory Agents; Child, Preschool; Etanercept; Follow-Up Studies; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Joint Diseases; Male; Methotrexate; Methylprednisolone; Prednisolone; Receptors, Tumor Necrosis Factor; Syndrome; Uveitis, Posterior | 2007 |